In 2013, Gral Medical reported a 10% revenue growth, at EUR18.2 million, supported by the oncology segment, laboratory division and medical imagistic centers.
The company’s investment budget for 2014 exceeds EUR2 million, part of a multiannual budget of around EUR5.5 million.
In 2013, Gral Medical opened its first hospital, OncoFort, in a EUR7 million investment, for which it estimates EUR4 million in revenue for the first year.
In January, OncoFort closed an academic and business partnership with MUVI (Medical University of Vienna International GmbH), targeting the development of the oncology medical system in Romania.
Owned by Georgeta and Robert Serban, the group’s biggest firms are Gral Medical and Medical Center Gral, which include 24 medical centers, one hospital, and a medical team of over 1,200 people.